Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP5MGP2 encodes a pseudogene related to the ATP synthase membrane subunit g. Unlike the canonical ATP5MG gene—which encodes a component of the mitochondrial ATP synthase complex involved in generating cellular ATP—ATP5MGP2 does not produce a protein product and has no known biological function, disease association, or relevance to drug targeting[5]. There is no evidence that ATP5MGP2 influences mitochondrial activity, cell signaling, or pathology. Its identification as a "pseudogene" signifies loss of coding capacity, and it is not recognized as a druggable or therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP Synthase Membrane Subunit G Pseudogene 2 (ATP5MGP2).